D-0581-2018 Class III Terminated
FDA drug recall D-0581-2018 was initiated by Osmotica Pharmaceutical Corp on Feb 28, 2018 and is designated Class III. Reason for recall: Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet. The recall status is terminated (terminated May 1, 2019). Affected quantity: 19,664 100-bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 14, 2018
- Initiation Date
- Feb 28, 2018
- Termination Date
- May 1, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19,664 100-bottles
Product description
Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10
Reason for recall
Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.
Distribution pattern
Nationwide in the USA
Code information
Lots: 170231B, 170232A, 170233A, 170234A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0581-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026